VANGUARD GROUP INC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 65 filers reported holding ENDOCYTE INC in Q3 2017. The put-call ratio across all filers is 2.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$62,593,000
+44.9%
3,524,390
+12.6%
0.00%0.0%
Q2 2018$43,196,000
+99.7%
3,130,131
+31.6%
0.00%
+100.0%
Q1 2018$21,627,000
+210.1%
2,379,164
+46.0%
0.00%
Q4 2017$6,974,000
+229.3%
1,629,409
+8.5%
0.00%
Q3 2017$2,118,000
+6.4%
1,501,847
+13.2%
0.00%
Q2 2017$1,991,000
-52.5%
1,327,297
-18.6%
0.00%
Q1 2017$4,189,000
+10.5%
1,629,836
+9.7%
0.00%
Q4 2016$3,791,000
-15.6%
1,486,339
+2.3%
0.00%
Q3 2016$4,491,000
+7.9%
1,453,378
+12.1%
0.00%
Q2 2016$4,162,000
+4.0%
1,296,418
+0.5%
0.00%
Q1 2016$4,000,000
-19.0%
1,290,274
+4.8%
0.00%
Q4 2015$4,937,000
-97.9%
1,231,259
-86.3%
0.00%
-100.0%
Q3 2015$234,254,000
+3804.2%
8,954,946
+674.7%
0.01%
Q2 2015$6,000,000
-11.0%
1,155,949
+7.3%
0.00%
Q1 2015$6,743,000
+5.0%
1,077,226
+5.5%
0.00%
Q4 2014$6,424,000
+6.0%
1,021,384
+2.5%
0.00%
Q3 2014$6,059,000
-10.9%
996,589
-3.5%
0.00%
-100.0%
Q2 2014$6,803,000
-71.8%
1,032,244
+1.9%
0.00%
-50.0%
Q1 2014$24,124,000
+153.1%
1,013,184
+13.6%
0.00%
+100.0%
Q4 2013$9,530,000
-21.7%
891,504
-2.4%
0.00%0.0%
Q3 2013$12,178,000
+6.1%
913,577
+4.5%
0.00%0.0%
Q2 2013$11,480,000874,2790.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2017
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders